Pol Cervera
CEO
The startup develops a genetic testing technology that sequences ribonucleic acid from small blood samples to identify gene expression variations in metabolic pathways. This analysis provides individuals with insights into biomarkers that can help prevent health issues, reduce sports injuries, and enhance recovery.
CEO